DK0812589T3 - Kombineret antipyretisk og analgetisk lægemiddel - Google Patents

Kombineret antipyretisk og analgetisk lægemiddel

Info

Publication number
DK0812589T3
DK0812589T3 DK95902295T DK95902295T DK0812589T3 DK 0812589 T3 DK0812589 T3 DK 0812589T3 DK 95902295 T DK95902295 T DK 95902295T DK 95902295 T DK95902295 T DK 95902295T DK 0812589 T3 DK0812589 T3 DK 0812589T3
Authority
DK
Denmark
Prior art keywords
isopropylantipyrine
combined
layer containing
antipyretic
analgesic drug
Prior art date
Application number
DK95902295T
Other languages
Danish (da)
English (en)
Inventor
Takashi Fujitsu
Kikuko Yoneda
Isao Ikebe
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26416787&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0812589(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of DK0812589T3 publication Critical patent/DK0812589T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95902295T 1993-12-10 1994-12-02 Kombineret antipyretisk og analgetisk lægemiddel DK0812589T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP31080393 1993-12-10
JP7563894 1994-04-14
PCT/JP1994/002031 WO1995015751A1 (en) 1993-12-10 1994-12-02 Combined antipyretic analgesic drug

Publications (1)

Publication Number Publication Date
DK0812589T3 true DK0812589T3 (da) 2000-11-13

Family

ID=26416787

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95902295T DK0812589T3 (da) 1993-12-10 1994-12-02 Kombineret antipyretisk og analgetisk lægemiddel

Country Status (13)

Country Link
US (1) US5686109A (enExample)
EP (1) EP0812589B1 (enExample)
JP (1) JP3168582B2 (enExample)
KR (1) KR100347631B1 (enExample)
CN (1) CN1094756C (enExample)
AT (1) ATE195418T1 (enExample)
DE (1) DE69425589T2 (enExample)
DK (1) DK0812589T3 (enExample)
ES (1) ES2148470T3 (enExample)
GR (1) GR3034434T3 (enExample)
PT (1) PT812589E (enExample)
TW (1) TW279799B (enExample)
WO (1) WO1995015751A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US6812985B1 (en) 1996-09-23 2004-11-02 Lg.Philips Lcd Co., Ltd. Liquid crystal display device
KR100251512B1 (ko) 1997-07-12 2000-04-15 구본준 횡전계방식 액정표시장치
JP4828707B2 (ja) * 2000-02-28 2011-11-30 武田薬品工業株式会社 固形圧縮製剤
DE60212475T2 (de) * 2001-03-14 2007-07-05 Pfizer Products Inc., Groton Pharmazeutische Tablette und ein Verfahren zu ihrer Herstellung
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
JP2003095944A (ja) * 2001-09-27 2003-04-03 Kowa Co 鎮痛剤
AU2004246837B2 (en) * 2003-06-06 2009-07-16 Ethypharm Orally-dispersible multilayer tablet
FR2855756B1 (fr) * 2003-06-06 2005-08-26 Ethypharm Sa Comprime orodispersible multicouche
CA2565029C (en) * 2004-05-21 2013-09-03 Lawrence Solomon Immediate release pharmaceutical tablets with height greater than width
WO2007058660A1 (en) * 2005-11-18 2007-05-24 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
US8202538B2 (en) * 2006-06-26 2012-06-19 Capricorn Pharma, Inc. Orally disintegrating layered compositions
JP2010500374A (ja) * 2006-08-08 2010-01-07 エーシーシーユー−ブレイク テクノロジーズ，インク． 複数の活性セグメントを含む薬剤の錠剤
EP2070520A1 (en) * 2007-12-11 2009-06-17 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media
JP2013121948A (ja) * 2011-11-07 2013-06-20 Daiichi Sankyo Healthcare Co Ltd 眠気が改善された感冒薬
JP6307874B2 (ja) * 2012-12-27 2018-04-11 大正製薬株式会社 レイヤリング粒子
JP7419057B2 (ja) * 2019-12-27 2024-01-22 ライオン株式会社 錠剤及びコーティング錠

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS609752B2 (ja) * 1979-11-09 1985-03-12 東邦新薬株式会社 新規な２−アセトキシベンズアミド誘導体、その製法及びそれを有効成分とする医薬
JPS5697224A (en) * 1979-12-28 1981-08-05 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
JPS61134315A (ja) * 1984-12-05 1986-06-21 Taisho Pharmaceut Co Ltd 解熱鎮痛剤
GB8623557D0 (en) * 1986-10-01 1986-11-05 Boots Co Plc Therapeutic agents
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
US5368861A (en) * 1989-10-26 1994-11-29 Nippon Shinyaku Co., Ltd. Gastric preparation with sustained release
US5213807A (en) * 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin
AU1560692A (en) * 1991-04-08 1992-11-02 Nippon Shinyaku Co. Ltd. Capsule
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof

Also Published As

Publication number Publication date
WO1995015751A1 (en) 1995-06-15
KR960706335A (ko) 1996-12-09
TW279799B (enExample) 1996-07-01
ATE195418T1 (de) 2000-09-15
EP0812589A4 (en) 1999-06-23
ES2148470T3 (es) 2000-10-16
DE69425589D1 (de) 2000-09-21
CN1142766A (zh) 1997-02-12
CN1094756C (zh) 2002-11-27
KR100347631B1 (ko) 2002-11-29
PT812589E (pt) 2000-11-30
EP0812589B1 (en) 2000-08-16
DE69425589T2 (de) 2001-01-04
US5686109A (en) 1997-11-11
JP3168582B2 (ja) 2001-05-21
GR3034434T3 (en) 2000-12-29
EP0812589A1 (en) 1997-12-17

Similar Documents

Publication Publication Date Title
TW279799B (enExample)
SE9600070D0 (sv) New oral pharmaceutical dosage forms
ID26340A (id) Kapsul ganda dengan penggunaan bahan-bahan aktif dalam berbagai macam pengobatan
SE9600071D0 (sv) New oral formulation of two active ingredients I
RU93058536A (ru) Орально вводимая форма лекарственного средства на основе пантопразола
IT1255522B (it) Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
DE3574934D1 (de) Pharmazeutische produkte mit erhoehter analgetischer wirksamkeit.
CA2316277A1 (en) Tablet for instant and prolonged release of one or more active substances
DE3878889D1 (de) Packung und verpackung mit sauerstoff absorbierenden mitteln.
DE3567025D1 (en) Polymerisable compounds with perfluoroalkyl groups, registration layers containing them and their use in dry lithography
DE69109557D1 (de) Überzogene feste Arzneiform mit Verabreichungsmöglichkeit im Dickdarm.
DE69327490D1 (de) Arzneimittel aus Polymer-Micellen mit physikalischer Einschlusswirkung
DE69821976D1 (de) Neue suppositoriumsform mit säureempfindliche wirkstoffe
ES2051698T3 (es) Granulos destinados a permanecer en el estomago.
NO963202L (no) Misbruksresistente tabletter
EP0648101A4 (en) ABSORBENT STRUCTURE FROM SEVERAL LAYERS.
DE3680741D1 (de) Hydraulisches spielausgleichselement mit kombinierter vorratsraumerweiterung und zumessvorrichtung.
FI943206A7 (fi) Tablettiformulaatio, jossa on sisäinen kuivausaine
NO891122D0 (no) Platinakoordinasjonsforbindelser og anvendelse av forbindelsene i kjemoterapi.
DE69434210D1 (de) Pharmazeutische antacidzusammensetzung
FI915437A0 (fi) Diagonaalinen viilukerrospuu
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
DE68917417D1 (de) Feine Bereiche aufweisende Verbundfolien aus Polyimid-Mischungen.
DE3581006D1 (de) Feste orale arzneiformen mit gestaffelter wirkung zur verabreichung von wirkstoffen mit geschwuere erzeugender nebenwirkung.
LV12067A (lv) 17B-N-vienaizvietota-karbamoil-4-aza-5alfa-androst-1-en-3-onu pielietojums medikamenta razosanai